Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Amy Halverson

Colon & Rectal Surgery Chicago, IL Medical Doctor

NPI 1568498186 CMS profile 407570

680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611

Open in the dashboard

General payments

$18,974

53 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Amy Halverson of Chicago, IL is reported in the CMS Open Payments database as having received $18,974 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $138 1
2023 General $143 1
2022 General $387 7
2021 General $328 4
2020 General $1,937 10
2019 General $16,042 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amy Halverson
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Amy Halverson were reported at $0. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Amy Halverson Colon & Rectal Surgery median Middle half National median
2019 $16,042 $443 $125–$2,179 $163
2020 $1,937 $167 $53–$931 $114
2021 $328 $207 $72–$1,272 $132
2022 $387 $341 $111–$1,587 $149
2023 $143 $322 $115–$1,420 $160
2024 $138 $328 $112–$1,354 $164
2025 $0 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Intuitive Surgical, Inc. $18,216 45 payments
  2. Covidien LP $160 2 payments
  3. Medtronic, Inc. $143 1 payment
  4. Stryker Corporation $139 1 payment
  5. Medical Device Business Services, Inc. $138 1 payment
  6. CONMED Corporation $119 2 payments
  7. Davol Inc. $59 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Education $14,250 5 payments
  2. Travel and Lodging $2,969 12 payments
  3. Food and Beverage $1,755 36 payments
Products named General payments · program years 2019–2024
  1. Da Vinci Surgical System $18,216 45 payments
  2. Signet $143 1 payment
  3. 1588 HD 3 CHIP CAMERA $139 1 payment
  4. Enseal $138 1 payment
  5. AIRSEAL $119 2 payments
  6. Phasix Mesh $59 1 payment
  7. Endo GIA $52 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

106

Median for Colorectal Surgery (Proctology): 106

Drug cost

$483

Median for Colorectal Surgery (Proctology): $1,614

Branded share of claims

35.8%

Median for Colorectal Surgery (Proctology): 35.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 11 $177
Neomycin Sulfate Generic 32 $153
Metronidazole Generic 36 $92
Ondansetron Odt Ondansetron Brand 27 $61

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,507 Part D prescribers listed as Colorectal Surgery (Proctology); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$79,436

Medicare's payments for the services billed

Medicare patients

153

Average age 74

Services billed

319

110 women, 43 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 53%
Cancer 38%
Ischemic heart disease 33%
Depression 32%
Chronic kidney disease 27%
Diabetes 26%
Osteoporosis 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record